D-0289-2021 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0289-2021 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Feb 22, 2021 and is designated Class III. Reason for recall: Subpotent The recall status is terminated (terminated Jan 21, 2022). Affected quantity: 37,400 cartons/60 vials per carton.

Recall details

Product Type
Drugs
Report Date
Mar 10, 2021
Initiation Date
Feb 22, 2021
Termination Date
Jan 21, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
37,400 cartons/60 vials per carton

Product description

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96

Reason for recall

Subpotent

Distribution pattern

Nationwide and Australia

Code information

Lot 10007, exp. date 01/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0289-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0289-2021. Report a data issue: hello@regdatalab.com.